Skip to main content

Topic

Drug Labeling

96 published works

  1. Drug & Device Law

    New Jersey OTC Preemption Decision

    By Michelle Yeary

                We don’t spend much time on this blog on over-the-counter (“OTC”) drugs, but when OTC crosses paths with preemption in our own backyard, we can’t help but be interested. …

  2. Health Industry Washington Watch

    FDA Small Entity Compliance Guidance: Toll Free Number Labeling for Drugs

    By Debra A. McCurdy

    This post was written by Erin Janssen. The FDA has published a Small Entity Compliance Guide entitled "Toll-Free Number Labeling and Related Requirements for Over-the-Counter and Prescription Drugs Marketed With…

  3. Health Industry Washington Watch

    FDA Issues Final Guidance on Risk Labeling for Prescription Drugs and Biological Products

    By Debra A. McCurdy

    This post was written by Erin Janssen and Areta Kupchyk.  On October 12, 2011 the FDA announced the availability of guidance for the industry entitled “Warnings and Precautions, Contraindications, and…

  4. Health Law Prof Blog

    Stacey B. Lee: “Generic Manufacturers’ Labeling Catch-22”

    By HealthLawProf

    Stacey B. Lee, Assistant Professor at Johns Hopkins University Carey Business School, posted, "Generic Manufacturers' Labeling Catch-22" on SSRN: In Wyeth v. Levine, the Supreme Court eliminated brand-name manufacturers’ ability…

  5. Ad Law Access

    Supreme Court Rules on Generic Drug Labeling Preemption

    By Kelley Drye

    On June 23, 2011, the Supreme Court rendered its decision in Pliva, Inc. v. Mensing holding that FDA regulations governing generic drug products directly conflict with and preempt state laws…

  6. Drug & Device Law

    While We Wait On Mensing, Another Circuit Shoots Down Generic Preemption

    By will

    We’re all curious to see what the Supreme Court does with the generic prescription drug manufacturers’ preemption defense in Actavis Elizabeth, LLC v. Mensing, which is scheduled for argument on…

  7. The Appellate Strategist

    Justice Kagan and the Future of Generic Drug Preemption

    By Kelly Savage

    US Supreme Court Will Decide Fate of Preemption Defense for Generic Companies this Term Since the decision of the Supreme Court in Wyeth v. Levine, 129 S.Ct. 1187 (2009), the…

  8. Drug & Device Law

    Thoughts on the Tegretol Complaint

    By Stephen McConnell

    A new lawsuit was filed in our favorite Judicial Hellhole, Madison County, Illinois, alleging that a pharmaceutical company failed to warn that African-Americans face an elevated risk of certain dermatological…

  9. Drug & Device Law

    Bam, bam, bam

    By dwalk, dwalk

    Bam, bam, bam. That’s the sound – not to be confused with Wham!, Bam!, or even Bamm-Bamm – of another nail being driven into the coffin of Conte v. Wyeth,…

  10. Health Industry Washington Watch

    FDA Guidance on Content and Format of the Dosage and Administration Section of Labeling

    By Debra A. McCurdy

    FDA issued a final guidance document entitled “Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products--Content and Format.'' The guidance identifies information that should be included…